IMPACT OF GUSELKUMAB INDUCTION THERAPY ON HISTOLOGIC AND COMBINED HISTOLOGIC AND ENDOSCOPIC OUTCOMES IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: WEEK 12 RESULTS FROM THE PHASE 3 QUASAR INDUCTION STUDY

Julian Panés  1     Bruce E. Sands  2     Laurent Peyrin-Biroulet  3     Shadi Yarandi  4     Gary KH Huang  4     Matthew Germinaro  4     Sunandini Sridhar  4     Patrick Branigan  4     Ye Miao  4     Hongyan Zhang  4     Xavier Hebuterne  5     Tibor Gyokeres  6     Fumihito Hirai  7     Tadakazu Hisamatsu  8     David T. Rubin  9     Brian G. Feagan  10    
1 Hospital Clínic de Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain
2 Icahn School of Medicine at Mount Sinai, New York, United States
3 Nancy University Hospital, Université de Lorraine, Nancy, France
4 Janssen Research & Development, LLC, Spring House, United States
5 CHU de Nice and University Côte d’Azur, Nice, France
6 North-Pest Central Hospital, Military Hospital, Budapest, Hungary
7 Fukuoka University Hospital, Fukuoka, Japan
8 Kyorin University, Tokyo, Japan
9 University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, United States
10 Alimentiv Inc, London, Canada

Topic
Endoscopy, Histopathology, IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing